Skip to main content

Medpace Holdings Inc

For the period ended Dec 31, 2023. Filed Feb 13, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 13, 2024

MEDP$672.93+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MEDPACE HOLDINGS, INC.
By:/s/ KEVIN M. BRADY
Name:Kevin M. Brady
Title:Chief Financial Officer
Date:February 13, 2024

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENT that the undersigned officers and directors of Medpace Holdings, Inc. do hereby constitute and appoint August J. Troendle and Kevin M. Brady, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

  • 83 -

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureCapacityDate
/s/ AUGUST J. TROENDLEChief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)
August J. TroendleFebruary 13, 2024
/s/ KEVIN M. BRADYChief Financial Officer (Principal Financial and Accounting Officer)
Kevin M. BradyFebruary 13, 2024
/s/ BRIAN T. CARLEYDirector
Brian T. CarleyFebruary 13, 2024
/s/ ROBERT O. KRAFTDirector
Robert O. KraftFebruary 13, 2024
/s/ FRED B. DAVENPORT JR.Director
Fred B. Davenport Jr.February 13, 2024
/s/ CORNELIUS P. MCCARTHY IIIDirector
Cornelius P. McCarthy IIIFebruary 13, 2024
/s/ ASHLEY M. KEATINGDirector
Ashley M. KeatingFebruary 13, 2024
/s/ DR. FEMIDA H. GWADRY-SRIDHARDirector
Dr. Femida H. Gwadry-SridharFebruary 13, 2024
  • 84 -
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.